ArticlebioRxiv : the preprint server for biology2026

PRMT5 inhibitors actively promote metastatic progression of lung adenocarcinoma.

Colin E Fowler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.